Cargando…

Human Papillomavirus Type16- L1 VLP Production in Insect Cells

Objective(s): Infection by high-risk papillomavirus is regarded as the major risk factor in the development of cervical cancer. Recombinant DNA technology allows expression of the L1 major capsid protein of HPV in different expression systems, which has intrinsic capacity to self-assemble into viral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdoli, Asghar, Soleimanjahi, Hoorieh, Fotouhi, Fatemeh, Teimoori, Ali, Pour Beiranvand, Shahram, Kianmehr, Zahra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mashhad University of Medical Sciences 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786099/ https://www.ncbi.nlm.nih.gov/pubmed/24106591

Ejemplares similares

Combination therapy using human papillomavirus L1/E6/E7 genes and archaeosome: a nanovaccine confer immuneadjuvanting effects to fight cervical cancer
por: Karimi, Hesam, et al.
Publicado: (2020)

Brucella abortus RB51 lipopolysaccharide influence as an adjuvant on the therapeutic efficacy of HPV16 L1 and HPV16 E7 DNA vaccines
por: Shirmohammadi, Masoumeh, et al.
Publicado: (2021)

Comparison of Biological and Immunological Characterization of Lipopolysaccharides From Brucella abortus RB51 and S19
por: Kianmehr, Zahra, et al.
Publicado: (2015)

Characterization and Transferring of Human Rotavirus Double-Layered Particles in MA104 Cells
por: Teimoori, Ali, et al.
Publicado: (2014)

Activation of calcium/calmodulin-dependent kinase II following bovine rotavirus enterotoxin NSP4 expression
por: Razavinikoo, Hadi, et al.
Publicado: (2015)

Determining Influenza Virus Shedding at Different Time Points in Madin-Darby Canine Kidney Cell Line
por: Abdoli, Asghar, et al.
Publicado: (2013)

Reconstruction of H(3)N(2) influenza virus based virosome in-vitro
por: Abdoli, Asghar, et al.
Publicado: (2013)

Further Stimulation of Cellular Immune Responses through Association of HPV-16 E6, E7 and L1 Genes in order to produce more Effective Therapeutic DNA Vaccines in Cervical Cancer Model
por: Fazeli, Maryam, et al.
Publicado: (2015)

Comparison of methylation patterns of E6 gene promoter region in the low-risk and high-risk human papillomavirus
por: Zafari, Ehsan, et al.
Publicado: (2018)

Kinetics of Oncolytic Reovirus T3D Replication and Growth Pattern in Mesenchymal Stem Cells
por: Banijamali, Razieh Sadat, et al.
Publicado: (2020)

Construction of Recombinant Bacmid Containing M2e-Ctxb and Producing the Fusion Protein in Insect Cell Lines
por: Mirzaei, Nima, et al.
Publicado: (2014)

Dissecting insect cell heterogeneity during influenza VLP production using single-cell transcriptomics
por: Silvano, Marco, et al.
Publicado: (2023)

Interaction between Borrelia miyamotoi variable major proteins Vlp15/16 and Vlp18 with plasminogen and complement
por: Schmidt, Frederik L., et al.
Publicado: (2021)

Gene Expression Analysis of Adapted Insect Cells during Influenza VLP Production Using RNA-Sequencing
por: Silvano, Marco, et al.
Publicado: (2022)

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)
por: Huber, Bettina, et al.
Publicado: (2017)

Histopathological characteristics and HPV status in cervical biopsy specimens diagnosed as flat condyloma
por: Nategh, Fatemeh, et al.
Publicado: (2023)

Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
por: Schellenbacher, Christina, et al.
Publicado: (2013)

Prevalence of herpes simplex viruses types 1 and 2 infections among suspected children of encephalitis in Kermanshah, Iran
por: Fakhredini, Kamal, et al.
Publicado: (2023)

Use of the piggyBac transposon to create HIV-1 gag transgenic insect cell lines for continuous VLP production
por: Lynch, Alisson G, et al.
Publicado: (2010)

Construction and Characterization of Insect Cell-Derived Influenza VLP: Cell Binding, Fusion, and EGFP Incorporation
por: Pan, Yi-Shin, et al.
Publicado: (2010)

Large-scale production and purification of VLP-based vaccines
por: Vicente, Tiago, et al.
Publicado: (2011)

Corneal Topography Patterns in the Tehran Eye Study: Warning About the High Prevalence of Patterns with A Skewed Radial Axis
por: Hashemi, Hassan, et al.
Publicado: (2014)

Development of Multiplex Reverse Transcription-Polymerase Chain Reaction for Simultaneous Detection of Influenza A, B and Adenoviruses
por: Nakhaie, Mohsen, et al.
Publicado: (2018)

Scan Pattern Characterization of Velodyne VLP-16 Lidar Sensor for UAS Laser Scanning
por: Lassiter, H. Andrew, et al.
Publicado: (2020)

Preparation and Characterization of PLGA Nanoparticles Containing Plasmid DNA Encoding Human IFN-lambda-1/IL-29
por: Amir Kalvanagh, Parisa, et al.
Publicado: (2019)

HSV-TK Expressing Mesenchymal Stem Cells Exert Inhibitory Effect on Cervical Cancer Model
por: Kenarkoohi, Azra, et al.
Publicado: (2020)

Optimization, characterization, comparison of self-assembly VLP of capsid protein L1 in yeast and reverse vaccinology design against human papillomavirus type 52
por: Firdaus, Moh Egy Rahman, et al.
Publicado: (2023)

MSCs loaded with oncolytic reovirus: migration and in vivo virus delivery potential for evaluating anti-cancer effect in tumor-bearing C57BL/6 mice
por: Seyed-Khorrami, Seyed-Mahmood, et al.
Publicado: (2021)

Therapeutic immunisation of rabbits with cottontail rabbit papillomavirus (CRPV) virus-like particles (VLP) induces regression of established papillomas
por: Govan, Vandana A, et al.
Publicado: (2008)

Bioengineered Bovine Papillomavirus L1 Protein Virus-like Particle (VLP) Vaccines for Enhanced Induction of CD8 T Cell Responses through Cross-Priming
por: Viscidi, Raphael P., et al.
Publicado: (2023)

Inhibition of HIV-1 replication using the CRISPR/cas9-no NLS system as a prophylactic strategy
por: Salimi-Jeda, Ali, et al.
Publicado: (2022)

Corrigendum to “Inhibition of HIV-1 replication using the CRISPR/noNLS-Cas9 system as a prophylactic strategy” <[Heliyon 8 (9) (2022) e10483]>
por: Salimi-Jeda, Ali, et al.
Publicado: (2022)

Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine
por: Gableh, Fateme, et al.
Publicado: (2016)

On the Effect of Thermodynamic Equilibrium on the Assembly Efficiency of Complex Multi-Layered Virus-Like Particles (VLP): the Case of Rotavirus VLP
por: Roldão, António, et al.
Publicado: (2012)

VLP‐factory™ and ADDomer(©): Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display
por: Sari‐Ak, Duygu, et al.
Publicado: (2021)

Analysis of Apoptosis in Cultured Human Vitrified Ovarian Tissue in the Presence of Leukemia Inhibitory Factor
por: Abdollahi, Maasoume, et al.
Publicado: (2018)

Systematic Review and Meta-Analysis of L1-VLP-Based Human Papillomavirus Vaccine Efficacy against Anogenital Pre-Cancer in Women with Evidence of Prior HPV Exposure
por: Miltz, Ada, et al.
Publicado: (2014)

RNA Phage VLP-Based Vaccine Platforms
por: Peabody, David S., et al.
Publicado: (2021)

Erythro-VLP: Erythrocyte Virus-Like-Particles
por: Himbert, Sebastian, et al.
Publicado: (2021)

Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic
por: López-Macías, Constantino
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_goaln8qdi0cb071epjl2rfthkb